NZ538833A - Process for preparing intermediates - Google Patents

Process for preparing intermediates

Info

Publication number
NZ538833A
NZ538833A NZ538833A NZ53883303A NZ538833A NZ 538833 A NZ538833 A NZ 538833A NZ 538833 A NZ538833 A NZ 538833A NZ 53883303 A NZ53883303 A NZ 53883303A NZ 538833 A NZ538833 A NZ 538833A
Authority
NZ
New Zealand
Prior art keywords
hydrogen
compound
formula
alkyl
hours
Prior art date
Application number
NZ538833A
Other languages
English (en)
Inventor
Prasad Koteswara Kapa
Xinglong Jiang
Eric M Loeser
Joel Slade
Mahavir Prashad
George Tein-San Lee
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NZ538833A publication Critical patent/NZ538833A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Press Drives And Press Lines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NZ538833A 2002-09-19 2003-09-18 Process for preparing intermediates NZ538833A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41192002P 2002-09-19 2002-09-19
US48024203P 2003-06-20 2003-06-20
PCT/EP2003/010416 WO2004026824A1 (en) 2002-09-19 2003-09-18 Process for preparing intermediates

Publications (1)

Publication Number Publication Date
NZ538833A true NZ538833A (en) 2008-05-30

Family

ID=32033579

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ538833A NZ538833A (en) 2002-09-19 2003-09-18 Process for preparing intermediates

Country Status (20)

Country Link
US (1) US7589216B2 (enExample)
EP (1) EP1542968B1 (enExample)
JP (1) JP2006503053A (enExample)
KR (1) KR20050057429A (enExample)
CN (1) CN100439334C (enExample)
AT (1) ATE417826T1 (enExample)
AU (1) AU2003273404B2 (enExample)
BR (1) BR0314592A (enExample)
CA (1) CA2499426A1 (enExample)
DE (1) DE60325390D1 (enExample)
DK (1) DK1542968T3 (enExample)
EC (1) ECSP055692A (enExample)
ES (1) ES2321504T3 (enExample)
MX (1) MXPA05003089A (enExample)
NO (1) NO20051867L (enExample)
NZ (1) NZ538833A (enExample)
PL (1) PL374961A1 (enExample)
PT (1) PT1542968E (enExample)
RU (1) RU2374227C2 (enExample)
WO (1) WO2004026824A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1406893T3 (da) 2001-06-15 2007-08-06 Vicuron Pharm Inc Bicykliske pyrrolidinforbindelser
WO2004026824A1 (en) 2002-09-19 2004-04-01 Novartis Ag Process for preparing intermediates
PL379008A1 (pl) 2003-02-21 2006-06-26 Novartis Ag Chemiczny sposób wytwarzania związków pośrednich do otrzymywania związków N-formylohydroksyloaminowych
GT200600196A (es) * 2005-05-23 2007-01-15 Compuestos n-formil de hidroxilamina
CN101434570B (zh) * 2007-11-16 2011-02-02 上海医药工业研究院 吡咯烷衍生物及其制备方法和应用
US11174288B2 (en) 2016-12-06 2021-11-16 Northeastern University Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU384814A1 (ru) * 1970-12-25 1973-05-29 Всесоюзный научно исследовательский институт тетических , натуральных душистых веществ СПОСОБ ПОЛУЧЕНИЯ р-МЕТИЛЗАМЕЩЕННЫХ со-ОКСИКАРБОНОВЫХ КИСЛОТ
US4123465A (en) * 1975-10-16 1978-10-31 Hoffmann-La Roche Inc. Chiral tertiary phosphines
JPS5377010A (en) * 1976-12-16 1978-07-08 Mitsui Toatsu Chem Inc Preparation of hydroxypivalic acid
JPS6030666B2 (ja) * 1980-08-20 1985-07-17 鐘淵化学工業株式会社 光学活性メルカプトカルボン酸の製造法
JPS5953839B2 (ja) * 1980-10-06 1984-12-27 鐘淵化学工業株式会社 (−)−α−ヒドロキシメチル酪酸の製造方法
JPH01149751A (ja) * 1987-12-08 1989-06-12 Agency Of Ind Science & Technol 2−n−ヘキシル−3−ヒドロキシ−n−デカン酸及びそのエステル
AU633260B2 (en) * 1988-08-09 1993-01-28 Genencor International, Inc. Chiral hydroxycarboxylic acids from prochiral diols
JPH0592948A (ja) * 1991-02-06 1993-04-16 Yoshitomi Pharmaceut Ind Ltd プロピオン酸アミド誘導体およびその医薬用途
PL194240B1 (pl) 1998-02-07 2007-05-31 British Biotech Pharm Zastosowanie pochodnych N-formylohydroksyloaminy i amidowa pochodna N-formylohydroksyloaminy
US6977141B2 (en) * 1998-02-10 2005-12-20 Vicuron Pharmaceuticals Inc. Direct adsorption scintillation assay for measuring enzyme activity and assaying biochemical processes
UY27192A1 (es) * 2001-03-01 2002-09-30 Smithkline Beecham Corp Inhibidores de peptido-deformilasa
AR036053A1 (es) * 2001-06-15 2004-08-04 Versicor Inc Compuestos de n-formil-hidroxilamina, un proceso para su preparacion y composiciones farmaceuticas
DK1406893T3 (da) * 2001-06-15 2007-08-06 Vicuron Pharm Inc Bicykliske pyrrolidinforbindelser
JP2006052138A (ja) * 2002-08-23 2006-02-23 Dainippon Sumitomo Pharma Co Ltd プロリン誘導体
WO2004026824A1 (en) 2002-09-19 2004-04-01 Novartis Ag Process for preparing intermediates
PL379008A1 (pl) 2003-02-21 2006-06-26 Novartis Ag Chemiczny sposób wytwarzania związków pośrednich do otrzymywania związków N-formylohydroksyloaminowych
TW200427458A (en) 2003-04-02 2004-12-16 Novartis Ag Crystalline N-formyl hydroxylamine compounds
WO2005000835A1 (en) 2003-06-26 2005-01-06 Novartis Ag Process for preparing intermediates useful to prepare certain antibacterial n-formyl hydroxylamines

Also Published As

Publication number Publication date
NO20051867D0 (no) 2005-04-18
HK1079513A1 (en) 2006-04-07
DK1542968T3 (da) 2009-04-20
MXPA05003089A (es) 2005-05-27
CN100439334C (zh) 2008-12-03
ATE417826T1 (de) 2009-01-15
DE60325390D1 (de) 2009-01-29
RU2005111600A (ru) 2006-10-27
US7589216B2 (en) 2009-09-15
PL374961A1 (en) 2005-11-14
EP1542968A1 (en) 2005-06-22
ECSP055692A (es) 2005-07-06
AU2003273404B2 (en) 2008-05-22
US20050261504A1 (en) 2005-11-24
PT1542968E (pt) 2009-03-25
CN1684945A (zh) 2005-10-19
AU2003273404A1 (en) 2004-04-08
KR20050057429A (ko) 2005-06-16
RU2374227C2 (ru) 2009-11-27
BR0314592A (pt) 2005-08-09
CA2499426A1 (en) 2004-04-01
NO20051867L (no) 2005-04-18
JP2006503053A (ja) 2006-01-26
ES2321504T3 (es) 2009-06-08
WO2004026824A1 (en) 2004-04-01
EP1542968B1 (en) 2008-12-17

Similar Documents

Publication Publication Date Title
CA2521487A1 (en) Process and intermediates for the preparation of pyrrolidine carboxylic acids
US20090131707A1 (en) Chemical process for the preparation of intermediates to obtain n-formyl hydroxylamine compounds
US20090118515A1 (en) Process for preparing intermediates useful to prepare certain antibacterial n-formyl hydroxylamines
JPH0762003B2 (ja) 5−オキソ−イミダゾリニル安息香酸類、ニコチン酸類及びキノリンカルボン酸類の製造法
EP1542968B1 (en) Process for preparing intermediates
EP0968997B1 (en) Process for S-aryl-L-cysteine and derivatives
KR960002371B1 (ko) 1-프로파르길-2,4-디옥소이미다졸리딘의 제조중간체 및 그 제조방법
HK1079513B (en) Process for preparing intermediates
ZA200501923B (en) Process for preparing intermediates.
WO2001060785A1 (en) Acetal hydroxylamine compounds
KR0136706B1 (ko) 광학 활성이 있는 3-아미노 피롤리딘 유도체의 제조방법
CN1143077A (zh) 制备卤代乙酰胺衍生物的方法
KR100774728B1 (ko) 펩티드 데포르밀라제 저해제로서 신규의 엔-포르밀히드록실아민 유도체 및 그 제조방법
EP1363623B1 (en) Peptide deformylase inhibitors
GB2100264A (en) Process for the preparation of D-alanine and derivatives thereof
KR900003391B1 (ko) 2-(5,5-디치환-4-옥소-2-이미다졸린-2-일)니코틴산 및 퀴놀린-3-카복실산류의 제법

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
EXPY Patent expired